Möchten Sie immer auf dem neuesten Stand bleiben?

FORESIGHT VCT PLCLEI: 213800GNTY699WHACF4614 April 2026 Final results31 December 2025 Foresight VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31...

Austin, United States, April 06, 2026 (GLOBE NEWSWIRE) -- Surrogacy Market Size & Growth Analysis: According to SNS Insider, The Surrogacy Market size is valued at USD 24.85 Billion in 2025 and...

PHILADELPHIA, April 06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...

Phase 3 studies of batoclimab in thyroid eye disease (TED) each failed to meet their primary endpoint; safety results were consistent with previous findingsPatients in the TED studies demonstrated...

Abaxx submits comments to NIST NCCoE proposed project on AI agent identity standards, focused on auditable, authorized agent actions in financial services

London, United Kingdom , April 01, 2026 (GLOBE NEWSWIRE) -- In 2026, the global landscape continues to evolve. The digitalization of global capital markets and the rapid innovation of financial...

PHILADELPHIA, April 01, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development...

Geneva, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) -- Conference Call to be Held on April 1 at 9:00am ET Audited FY 2025 revenue of $18 million, representing 66% growth year-over-yearEntered...

Company presents strong balance sheet with year-end cash of approximately $20 million and zero debt Revenue up 14.4% year-over-year Ra’anana, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Rail Vision...

BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical stage pharmaceutical and med-tech company focused on...